Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy - Nghiem, P; Bhatia, S; Lipson, E J (Journal of Clinical Oncology, 2019)
et al.